Advances Toward Improved Understanding And Treatment Of Uncommon Ovarian Cancer Types And Subtypes

Download Advances Toward Improved Understanding And Treatment Of Uncommon Ovarian Cancer Types And Subtypes full books in PDF, epub, and Kindle. Read online free Advances Toward Improved Understanding And Treatment Of Uncommon Ovarian Cancer Types And Subtypes ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!

Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes

Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes
Author :
Publisher : Frontiers Media SA
Total Pages : 170
Release :
ISBN-10 : 9782832555736
ISBN-13 : 283255573X
Rating : 4/5 (73X Downloads)

Book Synopsis Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes by : Robb Hollis

Download or read book Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes written by Robb Hollis and published by Frontiers Media SA. This book was released on 2024-10-22 with total page 170 pages. Available in PDF, EPUB and Kindle. Book excerpt: Ovarian cancer is an umbrella term for a collection of distinct disease entities (histotypes). Until now, the majority of research has focussed on the most common histotype, high-grade serous ovarian carcinoma (HGSOC), which accounts for 70% of cases. The less common histotypes – including endometrioid, clear cell, mucinous, low-grade serous, carcinosarcoma, and non-epithelial histotypes – have received far less research attention. Accordingly, while major advances in our understanding of HGSOC have led to molecularly-directed therapies that improve patient outcomes, progress in less common histotypes has lagged behind. Notably, many of the uncommon histotypes demonstrate resistance to conventional chemotherapy regimens, and their inherent biological differences suggest most are unlikely to respond to emerging molecular therapeutics designed to target the biology of common ovarian cancer types.


Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes Related Books

Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes
Language: en
Pages: 170
Authors: Robb Hollis
Categories: Medical
Type: BOOK - Published: 2024-10-22 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

Ovarian cancer is an umbrella term for a collection of distinct disease entities (histotypes). Until now, the majority of research has focussed on the most comm
Ovarian Cancer
Language: en
Pages: 366
Authors: Omer Devaja
Categories: Medical
Type: BOOK - Published: 2018-10-24 - Publisher: BoD – Books on Demand

DOWNLOAD EBOOK

Ovarian cancer management is a rapidly changing field with new treatment agents available as a result of a greater understanding of the pathogenesis of this dis
Blaustein's Pathology of the Female Genital Tract
Language: en
Pages: 1261
Authors: Ancel Blaustein
Categories: Medical
Type: BOOK - Published: 2011-01-10 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

New edition includes more than 350 new illustrations and 22 revised chapters Written by internationally recognized experts Each entry is structured the same way
Ovarian Cancer Biomarkers
Language: en
Pages: 236
Authors: Khalid El Bairi
Categories: Medical
Type: BOOK - Published: 2021-10-09 - Publisher: Springer Nature

DOWNLOAD EBOOK

This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in th
A National Cancer Clinical Trials System for the 21st Century
Language: en
Pages: 317
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-07-08 - Publisher: National Academies Press

DOWNLOAD EBOOK

The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However,